Research Interests
Genitourinary cancers
Treatment complications
Patient quality of life
Education
BS, Tufts University, Boston, MA
MD, University of North Carolina School of Medicine, Chapel Hill, NC
Internship, University of North Carolina Hospitals, Chapel Hill, NC
Meeting Abstracts/Presentations (recent)
Mavroidis P, Pearlstein K, Moon D, Sheets N, Kasibhatla M, Shen C, Zagar T, Marks L, Chera B, Das S, Wang K. NTCP modeling and dose-volume correlations of patient reported xerostomia 1 month after whole-brain radiation therapy. American Association of Physicists in Medicine Annual Meeting, San Antonio, TX, July 14-18, 2019. (Poster presentation.)
Pearlstein KA, Pryser E, Rankine LJ, Wang K, Mullins B, Holmes JA, Marks LB, Weiner AA. Marginal failures with stereotactic body radiation therapy (SBRT) for early stage lung cancer: Room for improvement? American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 21-24, 2018. (Poster presentation.)
Pearlstein KA, Saripalli S, Basak R, Sun JK, Lobos E, Wang AZ, Chen RC. Obesity and acute urinary and bowel quality of life (QOL) during prostate radiation therapy. American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 21-24, 2018. (Poster presentation.)
Pearlstein KA, Xu C, Deal A, Kaidar-Person O, Chen RC, Jones EL. Racial differences in cervical cancer histology and staging at presentation: a National Cancer Database analysis. American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 21-24, 2018. (Poster presentation.)
Pearlstein KA, Wang K, Amdur RJ, Weiss J, Grilley-Olson J, Zanation A, Hackman T, Thorp B, Blumberg J, Patel S, Sheets NC, Weissler M, Mendenhall WM, Chera BS. Continued improvement in quality of life (QoL) for patients with favorable risk HPV-associated oropharyngeal cancer > 1 year after completing de-intensified chemoradiotherapy. American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 21-24, 2018. (Oral presentation.)
Pryser E, Pearlstein KA, Rankine L, Wang K, Mullins B, Holmes J, Marks LB, Weiner AA. Dosimetric differences between ray-tracing and Monte Carlo algorithms in early stage lung cancer patients with marginal failures after SBRT. American Association of Physicists in Medicine Annual Meeting, Nashville, TN, July 29 – Aug. 2, 2018. (Poster presentation.)
Wang K, Pearlstein KA, Mahbooba Z, Sutton S, et al. Xerostomia is an unrecognized complication of whole brain radiotherapy and may be related to parotid dose: A prospective observational trial. American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
Wang K, Pearlstein KA, Patchett ND, Deal A, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer. American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
Pearlstein KA, Dooley J, Saripalli S, Sun J, Das S, Chen R, Mavroidis P. Fitting bladder doses to acute urinary symptoms during post-prostatectomy radiotherapy. American Association of Physicists in Medicine Annual Meeting, Nashville, TN, July 30-August 3, 2017. (Oral presentation.)
Pearlstein KA, Basak R, Chen RC. Cardiovascular disease and preventive care among cancer survivors: A population-based study. American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 2-6, 2017. (Poster presentation.)
Pearlstein KA, Basak R, Saripalli S, Sun JK, et al. Trajectory of patient-reported urinary and bowel symptom development during modern postprostatectomy radiation therapy. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
